礼来下调Zepbound入门剂量价格，减肥药竞争加剧推高行业压力

智通财经2025-12-01

智通财经APP获悉，随着与竞争对手诺和诺德的竞争日趋激烈，礼来再次下调其减肥药Zepbound入门剂量的价格。礼来在一份声明中表示，自周一起，现金自费购药者购买最低剂量的Zepbound每月费用为299美元，较之前价格优惠约50美元。次高剂量的价格将降至每月399美元，较此前现金自费价格下调约20%。礼来未调整更高剂量的价格，该系列仍维持每月499美元的售价。这是礼来与丹麦诺和诺德之间价格战的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2588780207?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","is_english":false,"pubTime":"2025-12-01 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588780207","market":"us","top_or_hot":-1,"title":"礼来下调Zepbound入门剂量价格，减肥药竞争加剧推高行业压力","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，随着与竞争对手诺和诺德的竞争日趋激烈，礼来再次下调其减肥药Zepbound入门剂量的价格。礼来在一份声明中表示，自周一起，现金自费购药者购买最低剂量的Zepbound每月费用为299美元，较之前价格优惠约50美元。次高剂量的价格将降至每月399美元，较此前现金自费价格下调约20%。礼来未调整更高剂量的价格，该系列仍维持每月499美元的售价。这是礼来与丹麦诺和诺德之间价格战的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1376226.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>礼来下调Zepbound入门剂量价格，减肥药竞争加剧推高行业压力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n礼来下调Zepbound入门剂量价格，减肥药竞争加剧推高行业压力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-01 22:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1376226.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，随着与竞争对手诺和诺德的竞争日趋激烈，礼来再次下调其减肥药Zepbound入门剂量的价格。礼来在一份声明中表示，自周一起，现金自费购药者购买最低剂量的Zepbound每月费用为299美元，较之前价格优惠约50美元。次高剂量的价格将降至每月399美元，较此前现金自费价格下调约20%。礼来未调整更高剂量的价格，该系列仍维持每月499美元的售价。这是礼来与丹麦诺和诺德之间价格战的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1376226.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1376226.html","article_id":"2588780207","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588780207","pubTimestamp":1764597669,"columns":[{"name":"产品发布","id":31,"label_key":"productRelease"}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，随着与竞争对手$诺和诺德$的竞争日趋激烈，$礼来$再次下调其减肥药Zepbound入门剂量的价格。礼来在一份声明中表示，自周一起，现金自费购药者购买最低剂量的Zepbound每月费用为299美元，较之前价格优惠约50美元。礼来未调整更高剂量的价格，该系列仍维持每月499美元的售价。这是该公司今年第二次通过LillyDirect平台下调Zepbound的价格。根据协议，礼来将下调Zepbound多剂量笔的价格。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LLY":"礼来"},"translate_title":"Eli Lilly (LLY.US) lowers Zepbound entry-dose price, intensified competition in weight loss drugs pushes up industry pressure","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/7aa6716c3b1c2d1623a04b911932a196","symbols_score_info":{"LLY":1.5},"content_text":"智通财经APP获悉，随着与竞争对手诺和诺德的竞争日趋激烈，礼来再次下调其减肥药Zepbound入门剂量的价格。礼来在一份声明中表示，自周一起，现金自费购药者购买最低剂量的Zepbound每月费用为299美元，较之前价格优惠约50美元。次高剂量的价格将降至每月399美元，较此前现金自费价格下调约20%。礼来未调整更高剂量的价格，该系列仍维持每月499美元的售价。这是礼来与丹麦诺和诺德之间价格战的最新动向，此举大幅降低了患者开始使用这类畅销药物的初始成本。诺和诺德已于11月下调了其现金自费价格。目前，在其直接面向消费者的在线门户NovoCare上，Ozempic和Wegovy的入门剂量前两个月价格为每月199美元，之后将升至每月349美元。礼来的折扣通过其直接面向消费者的在线平台LillyDirect提供。患者通常从较低剂量开始用药，随后为达到更好减重效果而增加剂量。礼来美国公司总裁伊利亚·尤法表示，此次降价彰显了公司提升肥胖症治疗可及性的承诺。这是该公司今年第二次通过LillyDirect平台下调Zepbound的价格。他在声明中称：“我们将持续努力提供更多选择，扩展给药装置类型并开辟新的获取途径，以便更多患者能够获得所需药物。”礼来与诺和诺德在利润丰厚的全球肥胖症治疗市场中展开正面竞争，分析师预计该市场规模到本十年末将达到1000亿美元。两家公司一直在寻找竞争优势，包括与管控美国药品福利的机构达成协议、为现金自费客户提供折扣，以及近期推出的直接面向雇主的新计划。与此同时，长期备受关注的减肥药价格正面临来自特朗普政府降低美国民众用药成本行动所带来的更大压力。周二，白宫宣布已通过谈判为联邦老年医保计划患者争取到Ozempic和Wegovy高达71%的折扣。该降价措施将于2027年生效。此外，诺和诺德与礼来均在与政府达成的协议中同意降低其在美国的价格，该协议同时适用于联邦医保患者和现金自费客户。根据协议，礼来将下调Zepbound多剂量笔的价格。特朗普政府推动的该协议将于2026年开始生效。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588780207","isCrawlerRequest":true}